Publication date: Dec 05, 2019 Department of Medicine Chief, Melanoma and Immunotherapeutics Service Early Drug Development Service “What are the biggest issues with immune checkpoint blockade? Concepts Keywords Adrenal Insufficiency ... Read more

Publication date: Dec 04, 2019 The overall survival rate in patients with melanoma has increased exponentially in the past decade. But thanks to the use of combinations in the treatment ... Read more

Publication date: Dec 04, 2019 Adil Daud, MD, clinical professor, Department of Medicine (Hematology/Oncology) and director, Melanoma Clinical Research, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, ... Read more

Publication date: Dec 02, 2019 Deborah J. Wong, MD, PhD, provides an overview of the case of a patient with BRAF-mutated metastatic melanoma. For more resources and information regarding anticancer ... Read more

Publication date: Dec 02, 2019 A review of the data supporting BRAF/MEK inhibition for patients with metastatic melanoma and a BRAF V600E mutation. For more resources and information regarding anticancer ... Read more

Publication date: Dec 02, 2019 Adil Daud, MD, a clinical professor in the Department of Medicine (Hematology/Oncology) at the University of California, San Francisco and director of Melanoma Clinical Research ... Read more

Publication date: Dec 01, 2019 Michelle Davey, Senior Clinical Psychologist from Melanoma Institute Australia, discusses coping strategies and how to live well when faced with a melanoma diagnosis. Concepts Keywords ... Read more

Publication date: Dec 02, 2019 Professor Georgina Long, Co-Medical Director at Melanoma Institute Australia, provides an insight in to the latest drug treatments for melanoma. Concepts Keywords Aban Scar Air ... Read more

Publication date: Dec 02, 2019 Associate Professor Robyn Saw, a surgeon from Melanoma Institute Australia, gives an insight into the latest surgical treatments for melanoma intervention and how different disciplines ... Read more

Publication date: Dec 02, 2019 Professor Richard Scolyer, Co-Medical Director at Melanoma Institute Australia, discusses the role of the pathologist in melanoma research, diagnosis, prognosis, sentinel node biposy and personalised ... Read more